Results 51 to 60 of about 410,320 (404)

Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea.

open access: yesJAMA cardiology, 2022
Importance Diagnosis of heart failure with preserved ejection fraction (HFpEF) among dyspneic patients without overt congestion is challenging. Multiple diagnostic approaches have been proposed but are not well validated against the independent gold ...
Y. Reddy   +13 more
semanticscholar   +1 more source

Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry

open access: yesBalkan Medical Journal, 2019
Background: Clinical characteristics of patients with heart failure may vary geographically. However, limited data are available regarding the geographical differences of patients with heart failure and preserved ejection fraction.
Bülent Özlek   +19 more
doaj   +1 more source

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.

open access: yesJAMA cardiology, 2021
Importance Coronary artery disease (CAD) and coronary microvascular dysfunction (CMD) may contribute to the pathophysiologic characteristics of heart failure with preserved ejection fraction (HFpEF).
MN Kosiborod   +32 more
semanticscholar   +1 more source

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction [PDF]

open access: yesThe International Journal of Cardiovascular Imaging, 2019
The aim of this study was to determine whether left atrial ejection fraction (LAEF) quantified with cardiovascular magnetic resonance (CMR) was different between heart failure with preserved ejection fraction (HFpEF) and controls, and its relation to prognosis. As part of our single-centre, prospective, observational study, 188 subjects (HFpEF n = 140,
Adrian S. H. Cheng   +12 more
openaire   +3 more sources

Biomarkers in heart failure with preserved ejection fraction [PDF]

open access: yesNetherlands Heart Journal, 2016
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and performance of biomarkers in sub-studies of randomised clinical trials, where the vast majority of the patients suffered from heart failure with reduced ejection fraction (HFrEF), and not with preserved ejection fraction (HFpEF). As a result, there is a
A. R. Van der Velde   +2 more
openaire   +3 more sources

Heart failure with preserved ejection fraction: insights from recent clinical researches [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2020
Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for nearly half of the cases of HF and its incidence might be increasing with the aging society.
Mi-Na Kim, Seong-Mi Park
doaj   +1 more source

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction

open access: yesCirculation, 2021
Supplemental Digital Content is available in the text. Background: Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure with preserved ejection fraction, but additional data are needed
M. Packer   +17 more
semanticscholar   +1 more source

An orbital release model for the Orion BN/KL fingers [PDF]

open access: yes, 2021
We present a simple model in which the bullets that produce the "Orion fingers" (ejected by the BN/KL object) are interpreted as protoplanets or low mass protostars in orbit around a high mass star that has a supernova explosion. As the remnant of the SN explosion has only a small fraction of the mass of the pre-supernova star, the orbiting objects ...
arxiv   +1 more source

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

open access: yesEuropean Heart Journal, 2019
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'.
B. Pieske   +23 more
semanticscholar   +1 more source

Nicotinamide for the treatment of heart failure with preserved ejection fraction

open access: yesScience Translational Medicine, 2021
The NAD+ precursor nicotinamide improves diastolic dysfunction caused by aging, hypertension, or metabolic syndrome in rodents. Diet and diastolic dysfunction Increasing nicotinamide adenine dinucleotide (NAD+) can mimic some of the benefits of caloric ...
M. Abdellatif   +43 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy